Unique molecules represent a exciting landscape in drug discovery. These particular small structures of protein residues offer remarkable promise for targeting previously processes involved in multiple diseases. Preliminary research demonstrate these can provide specific binding and exhibit favorable pharmacokinetic characteristics, opening ways to